{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:16:14Z","timestamp":1792628174601,"version":"4.5.0"},"reference-count":40,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.3892\/ol.2012.614","type":"journal-article","created":{"date-parts":[[2012,2,20]],"date-time":"2012-02-20T12:51:02Z","timestamp":1329742262000},"page":"1119-1123","source":"Crossref","is-referenced-by-count":65,"title":["Aberrant expression of Treg-associated cytokine IL-35 along with IL-10 and TGF-\u03b2 in acute myeloid leukemia"],"prefix":"10.3892","volume":"3","author":[{"given":"HAO","family":"WU","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PENG","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NA","family":"SHAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JINGJING","family":"MA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MIN","family":"JI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIULIAN","family":"SUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DAOXIN","family":"MA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHUNYAN","family":"JI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,2,20]]},"reference":[{"key":"key20180108091335_b1-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJM199909303411407","article-title":"Acute myeloid leukemia","volume":"341","author":"Lowenberg","year":"1999","journal-title":"N Engl J Med"},{"key":"key20180108091335_b2-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(06)69780-8","article-title":"Acute myeloid leukaemia","volume":"368","author":"Estey","year":"2006","journal-title":"Lancet"},{"key":"key20180108091335_b3-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.molonc.2010.04.008","article-title":"High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V","volume":"4","author":"Fritsche-Polanz","year":"2010","journal-title":"Mol Oncol"},{"key":"key20180108091335_b4-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2249.2010.04197.x","article-title":"Immunotherapy prospects for acute myeloid leukaemia","volume":"161","author":"Barrett","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"key20180108091335_b5-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1600-0609.2005.00537.x","article-title":"Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients","volume":"75","author":"Wang","year":"2005","journal-title":"Eur J Haematol"},{"key":"key20180108091335_b6-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1158\/1078-0432.CCR-08-3010","article-title":"Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia","volume":"15","author":"Szczepanski","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180108091335_b7-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2172-11-38","article-title":"Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells","volume":"11","author":"Ersvaer","year":"2010","journal-title":"BMC Immunol"},{"key":"key20180108091335_b8-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/ijc.25791","article-title":"Elevated frequencies of CD4(+) CD25(+) CD127(lo) regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia","volume":"129","author":"Shenghui","year":"2011","journal-title":"Int J Cancer"},{"key":"key20180108091335_b9-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-61737-979-6_1","article-title":"Regulatory T cells: history and perspective","volume":"707","author":"Sakaguchi","year":"2011","journal-title":"Methods Mol Biol"},{"key":"key20180108091335_b10-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"12041","DOI":"10.1073\/pnas.94.22.12041","article-title":"Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin","volume":"94","author":"Devergne","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108091335_b11-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"key20180108091335_b12-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br J Haematol"},{"key":"key20180108091335_b13-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","article-title":"Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group","volume":"103","author":"Bennett","year":"1985","journal-title":"Ann Intern Med"},{"key":"key20180108091335_b14-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1200\/JCO.1990.8.5.813","article-title":"Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia","volume":"8","author":"Cheson","year":"1990","journal-title":"J Clin Oncol"},{"key":"key20180108091335_b15-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.coi.2007.02.004","article-title":"Regulatory T cells and cancer","volume":"19","author":"Wang","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"key20180108091335_b16-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1385\/IR:32:1-3:155","article-title":"CD25+ CD4+ regulatory T-cells in cancer","volume":"32","author":"Linehan","year":"2005","journal-title":"Immunol Res"},{"key":"key20180108091335_b17-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1182\/blood-2005-08-3376","article-title":"Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma","volume":"107","author":"Yang","year":"2006","journal-title":"Blood"},{"key":"key20180108091335_b18-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2003-07-2594","article-title":"Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma","volume":"103","author":"Marshall","year":"2004","journal-title":"Blood"},{"key":"key20180108091335_b19-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2567.2011.03439.x","article-title":"Both CD4+ FoxP3+ and CD4+ FoxP3- T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro","volume":"133","author":"Lindqvist","year":"2011","journal-title":"Immunology"},{"key":"key20180108091335_b20-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.leukres.2010.08.010","article-title":"Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease","volume":"35","author":"D\u2019Arena","year":"2011","journal-title":"Leuk Res"},{"key":"key20180108091335_b21-ol-03-05-1119","first-page":"677","article-title":"Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia","volume":"20","author":"Giannopoulos","year":"2008","journal-title":"Oncol Rep"},{"key":"key20180108091335_b22-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1182\/blood-2005-09-3671","article-title":"In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma","volume":"107","author":"Beyer","year":"2006","journal-title":"Blood"},{"key":"key20180108091335_b23-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ni.1952","article-title":"IL-35-mediated induction of a potent regulatory T cell population","volume":"11","author":"Collison","year":"2010","journal-title":"Nat Immunol"},{"key":"key20180108091335_b24-ol-03-05-1119","first-page":"131","article-title":"IL-35, an anti-inflammatory cytokine which expands CD4+CD25+ Treg Cells","volume":"24","author":"Castellani","year":"2010","journal-title":"J Biol Regul Homeost Agents"},{"key":"key20180108091335_b25-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/eji.200737810","article-title":"IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells","volume":"37","author":"Niedbala","year":"2007","journal-title":"Eur J Immunol"},{"key":"key20180108091335_b26-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.4049\/jimmunol.0902739","article-title":"IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10","volume":"184","author":"Kochetkova","year":"2010","journal-title":"J Immunol"},{"key":"key20180108091335_b27-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00002371-200109000-00002","article-title":"Cytokines and immune response in the tumor microenvironment","volume":"24","author":"Mocellin","year":"2001","journal-title":"J Immunother"},{"key":"key20180108091335_b28-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1182\/blood.V88.3.1035.bloodjournal8831035","article-title":"Interleukin-10 gene expression in adult T-cell leukemia","volume":"88","author":"Mori","year":"1996","journal-title":"Blood"},{"key":"key20180108091335_b29-ol-03-05-1119","first-page":"1910","article-title":"Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia","volume":"9","author":"Bruserud","year":"1995","journal-title":"Leukemia"},{"key":"key20180108091335_b30-ol-03-05-1119","first-page":"476","article-title":"Interleukin (IL)-10, but not IL-4 or IL-13, inhibits cytokine production and growth in juvenile myelomonocytic leukemia cells","volume":"57","author":"Iversen","year":"1997","journal-title":"Cancer Res"},{"key":"key20180108091335_b31-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0925-5710(97)00070-4","article-title":"Interleukin-10 inhibits the autocrine growth of leukemic blast cells from patients with acute myeloblastic leukemia","volume":"66","author":"Asano","year":"1997","journal-title":"Int J Hematol"},{"key":"key20180108091335_b32-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/10428190109057966","article-title":"In vivo effects of IL-4, IL-10, and amifostine on cytokine production in patients with acute myelogenous leukemia","volume":"41","author":"Tao","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"key20180108091335_b33-ol-03-05-1119","first-page":"81","article-title":"Transforming growth factor-beta","volume":"12","author":"Massague","year":"1992","journal-title":"Cancer Surv"},{"key":"key20180108091335_b34-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1182\/blood.V95.12.3945","article-title":"Differential expression of a novel C-terminally truncated splice form of SMAD5 in hematopoietic stem cells and leukemia","volume":"95","author":"Jiang","year":"2000","journal-title":"Blood"},{"key":"key20180108091335_b35-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.onc.1204057","article-title":"Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis","volume":"20","author":"Imai","year":"2001","journal-title":"Oncogene"},{"key":"key20180108091335_b36-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"40282","DOI":"10.1074\/jbc.C000485200","article-title":"Inhibition of the transforming growth factor \u03b21 signaling pathway by the AML1\/ETO leukemia-associated fusion protein","volume":"275","author":"Jakubowiak","year":"2000","journal-title":"J Biol Chem"},{"key":"key20180108091335_b37-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1073\/pnas.0408831102","article-title":"AML1-ETO and C-KIT mutation\/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec","volume":"102","author":"Wang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108091335_b38-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood.V75.7.1540.1540","article-title":"The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis","volume":"75","author":"Terui","year":"1990","journal-title":"Blood"},{"key":"key20180108091335_b39-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.4049\/jimmunol.150.6.2418","article-title":"Transforming growth factor-beta potentiates vitamin D3-induced terminal monocytic differentiation of human leukemic cell lines","volume":"150","author":"Testa","year":"1993","journal-title":"J Immunol"},{"key":"key20180108091335_b40-ol-03-05-1119","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2249.2009.04011.x","article-title":"Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia","volume":"158","author":"Wu","year":"2009","journal-title":"Clin Exp Immunol"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2012.614\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T21:48:56Z","timestamp":1686779336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2012.614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,20]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,2,20]]},"published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.3892\/ol.2012.614"],"URL":"https:\/\/doi.org\/10.3892\/ol.2012.614","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,20]]}}}